? Antibiotic resistance is a growing problem that affects the treatment of almost all infectious diseases. The cost of treating antibiotic resistant infections is close to $30 billion/year in the United States alone. The identification of genes and mechanisms underlying resistant phenotypes is a focus of current drug discovery efforts wherein the goal is to develop combination therapies that target a process essential for bacterial survival and simultaneously render resistance mechanisms ineffective. On the way to this goal we believe it is necessary to understand the mechanisms by which resistant pathogens can once again be made sensitive to antibiotics and then exploit these mechanisms in the development of combination therapy. The objective of this study is to develop a new genomics based approach for the efficient identification of genes whose overexpression restores sensitivity to antibiotics in resistant pathogens and apply that approach. In the case of aminoglycoside resistant Pseudomonas aeruginosa, a significant cause of morbidity and mortality, particularly in cystic fibrosis patients, in addition to studying naturally occurring resistant clinical isolates of P. aeruginosa, two clinically relevant mechanisms of resistance with be engineered into PAO1 a sensitive strain of P. aeruginosa. This will be done with a plasmid either expressing the enzyme 6""""""""-N-aminoglycoside acetyltransferase7, which modifies aminoglycosides or expressing the phoP gene, which reduces bacterial permeability to aminoglycosideds. Transforming these resistant strains with a genomic library will then allow for a DNA microarray based method to identify clones expressing genomic inserts which are absent in a bacterial population grown in the presence of aminoglycosides. It is these inserts which presumably restore a sensitive phenotype to these resistant strains, causing bacterial death and an absence of these inserts in the population. Confirmatory and then mechanistic studies will be carried out to further elucidate the mechanisms behind the sensitivity phenotypes discovered. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI055773-02
Application #
6741835
Study Section
Special Emphasis Panel (ZAI1-AR-M (M1))
Program Officer
Peters, Kent
Project Start
2003-05-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2006-04-30
Support Year
2
Fiscal Year
2004
Total Cost
$220,433
Indirect Cost
Name
University of Colorado at Boulder
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
007431505
City
Boulder
State
CO
Country
United States
Zip Code
80309
Struble, Julie M; Gill, Ryan T (2009) Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa. PLoS One 4:e6576
Lynch, Michael D; Warnecke, Tanya; Gill, Ryan T (2007) SCALEs: multiscale analysis of library enrichment. Nat Methods 4:87-93
Struble, Julie M; Gill, Ryan T (2006) Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother 50:2506-15
Lynch, Michael D; Gill, Ryan T (2006) Broad host range vectors for stable genomic library construction. Biotechnol Bioeng 94:151-8
Dai, MingHua; Ziesman, Sara; Ratcliffe, Thomas et al. (2005) Visualization of protoplast fusion and quantitation of recombination in fused protoplasts of auxotrophic strains of Escherichia coli. Metab Eng 7:45-52